Studies towards the synthesis of methionine aminopeptidase inhibitors: Diversification utilizing a ROMP-derived coupling reagent

Journal of Combinatorial Chemistry

Volumn 10, Issue 2, 2008, Pages 195-203

  Vedantham, Punitha ^a   Zhang, Mianji ^a   Gor, Parul J ^a   Huang, Min ^a   Georg, Gunda I ^a,c   Lushington, Gerald H ^a   Mitscher, Lester A ^a   Ye, Qi Zhuang ^a,b   Hanson, Paul R ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; METHIONYL AMINOPEPTIDASE; PROTEINASE INHIBITOR;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; ENZYMOLOGY; ESCHERICHIA COLI; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

AMINOPEPTIDASES; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; INDICATORS AND REAGENTS; MODELS, MOLECULAR; PROTEASE INHIBITORS;

EID: 42449141546     PISSN: 15204766     EISSN: None     Source Type: Journal    
DOI: 10.1021/cc7000869     Document Type: Article

References (49)

1. Bradshaw, R. A.; Brickey, W. W.; Walker, W. Trends Biochem. Sci. 1998, 23, 263-267.
2. Chang, S.-Y.; McGary, E. C.; Chang, S. J. Bacteriol. 1989, 171, 4071-4072.
3. Miller, C. G.; Kukral, A. M.; Miller, J. L.; Movva, N. R. J. Bacteriol. 1989, 171, 5215-5217.
4. (a) D'souza, V. M.; Holz, R. C. Biochemistry 1999, 38, 11079-11085.
5. (b) Li, J.-Y.; Chen, L.-L.; Cui, Y.-M.; Luo, Q.-L.; Li, J.; Nan, F.-J.; Ye, Q.-Z. Biochem. Biophys. Res. Commun. 2003, 307, 172-179.
6. (a) Oefner, C.; Douangamath, A.; D'Arcy, A.; Hafeli, S.; Mareque, D.; MacSweeney, A.; Padilla, J.; Pierau, S.; Schulz, H.; Thormann, M.; Wadman, S.; Dale, G. E. J. Mol. Biol. 2003, 332, 13-21.
7. (b) Wang, J.; Sheppard, G. S.; Lou, P.; Kawai, M.; Park, C.; Egan, D. A.; Schneider, A.; Bouska, J.; Lesniewski, R.; Henkin, J. Biochemistry 2003, 42, 5035-5042.
8. Cork, D.; Hird, N. Drug Discovery Today 2002, 7, 56-73.
9. An, H.; Cook, P. D. Chem. Rev. 2000, 100, 3311-3340.
10. Although considerable improvements have been made in this area in recent years (e.g., FTIR, MALDI-MS, Gelphase, and MAS NMR, etc.), these techniques still do not provide analysis comparable to that of conventional solution-phase techniques (e.g., TLC, GC-MS, LC-MS, SFC-MS, NMR, etc.).
11. (a) For references on monitoring solid-phase reactions, see: Bing, Y. Acc. Chem. Res. 1998, 31, 621-630.
12. (b) Enger, B. J.; Bradley, M. Drug Discovery Today 1997, 2, 102-109.
13. (a) Booth, R. J.; Hodges, J. C. Acc. Chem. Res. 1999, 32, 18-26.
14. (b) Ley, S. V.; Baxendale, I. R.; Bream, R. N.; Jackson, P. S.; Leach, A. G.; Longbottom, D. A.; Nesi, M.; Scott, J. S.; Storer, R. I.; Taylor, S. J. J. Chem. Soc., Perkin Trans. 1 2000, 3815-4195.
15. (c) Kirschning, A.; Monenschein, H.; Wittenberg, R. Angew. Chem., Int. Ed. 2001, 40, 650-679.
16. (d) Eames, J.; Watkinson, M. Eur. J. Org. Chem. 2001, 1213-1224.
17. (a) Zhang, W. Curr. Opin. Drug Discovery Dev. 2004, 7, 784-797.
18. (b) Zhang, W. Tetrahedron 2003, 59, 4475-4489.
19. (a) Curran, D. P. Pharmaceutical News 2002, 9, 179-188.
20. (b) Studer, A.; Hadida, S.; Ferritto, R.; Kim, S.-Y.; Jeger, P.; Wipf, P.; Curran, D. P. Science 1997, 275, 823-826.
21. (a) Bergbreiter, D. E.; Li, J. Top. Curr. Chem. 2004, 242, 113-176.
22. (b) Haag, R; Roller, S. Top. Curr. Chem. 2004, 242, 1-42.
23. (a) Song, G.; Cai, Y.; Peng, Y. J. Comb. Chem. 2005, 7, 561-566.
24. (b) He, X.; Chan, T. H. Tetrahedron 2006, 62, 3389-3394.
25. (c) Qian, W.; Jin, E.; Bao, W.; Zhang, Y. Angew. Chem., Int. Ed. 2005, 44, 952-955.
26. Barrett, A. G. M.; Hopkins, B. T.; Köbberling, J. Chem. Rev. 2002, 102, 3301-3324.
27. Flynn, D. L.; Hanson, P. R.; Berk, S. C.; Makara, G. M. Curr. Opin. Drug Discovery Dev. 2002, 5, 571-579.
28. (a) Buchmeiser, M. R.; Atzl, N.; Bonn, G. K. J. Am. Chem. Soc. 1997, 119, 9166-9174.
29. (b) Buchmeiser, M. R.; Wurst, K. J. Am. Chem. Soc. 1999, 121, 11101-11107.
30. (c) Buchmeiser, M. R. Metathesis Polymerization: A Versatile Tool for the Synthesis of Surface-Functionalized Supports and Monolithic Materials. In Handbook of Metathesis; Grubbs, R. H., Ed.; Wiley-VCH: Weinheim, Germany, 2003; Vol. 3, pp 226-254.
31. (a) Bolm, C.; Dinter, C. L.; Seger, A.; Höcker, H.; Brozio, J. J. Org. Chem. 1999, 64, 5730-5731.
32. (b) Bolm, C.; Tanyeli, C.; Grenz, A.; Dinter, C. L. Adv. Synth. Catal. 2002, 344, 649-656.
33. (a) Harned, A. M.; Zhang, M.; Vedantham, P.; Mukherjee, S.; Herpel, R. H.; Flynn, D. L.; Hanson, P. R. Aldrichim. Acta 2005, 38, 3-16.
34. (b) Harned, A. M.; Probst, D. A.; Hanson, P. R. The Use of Olefin Metathesis in Combinatorial Chemistry: Supported and Chromatography-Free Syntheses In Handbook of Metathesis, Grubbs, R. H., Ed.; Wiley-VCH: Weinheim, Germany, 2003; Vol. 2, pp 361-402.
35. (c) Harned, A. M.; Sherrill, W. M.; Flynn, D. L.; Hanson, P. R. Tetrahedron 2005, 61, 12093-12099.
36. (d) Zhang, M.; Flynn, D. L.; Hanson, P. R. J. Org. Chem. 2007, 72, 3194-3198.
37. 2GOACC., implies that the oligomers were prepared by ROM polymerization using the second generation Grubbs catalyst and could be of varying length including n = 50, 75, or 100.
38. Zhang, M.; Vedantham, P.; Flynn, D. L.; Hanson, P. R. J. Org. Chem. 2004, 69, 8340-8344.
39. Ye, Q.-Z.; Xie, S.-X.; Huang, M.; Huang, W.-J.; Lu, J.-P.; Ma, Z.-Q. J. Am. Chem. Soc. 2004, 126, 13940-13941.
40. While various protocols to remove the excess boronic acids with scavengers were attempted, none of these methods gave us significantly cleaner products. While most of the boronic acid could be scavenged by treatment with aqueous NaOH, as evident by TLC, NMR indicated unreacted boronic anhydride was present necessitating the use of high-throughput chromatographic purification, (a) For use of a polystryene diethanolamine-derived scavenger, see: Hall, D. G.; Tailor, J.; Gravel, M. Angew. Chem., Int. Ed. 1999, 38, 3064-3067.
41. 2, see: Molander, G. A.; Biolatto, B. J. Org. Chem. 2003, 68, 4302-4314.
42. Morris, G. M.; Goodsell, D. S.; Halliday, R. S.; Huey, R.; Hart, W. E.; Belew, R. K.; Olson, A. J. J. Comput. Chem. 1998, 19, 1639-1662.
43. Gille, A.; Lushington, G. H.; Mou, T.-C.; Doughty, M. B.; Johnson, R. A.; Seifert, R. J. Biol. Chem. 2004, 279, 19955-19969.
44. Guo, J.; Hurley, M. M.; Wright, J. B.; Lushington, G. H. J. Med. Chem. 2004, 47, 5492-5500.
45. Gille, A.; Guo, J.; Mou, T.-C.; Doughty, M. B.; Lushington, G. H.; Seifert, R. Biochem. Pharmacol. 2005, 71, 89-97.
46. SYBYL 6.9.2; The Tripos Associates: St. Louis, MO, 2004.
47. Cruciani, G.; Crivori, P.; Carrupt, P.-A.; Testa, B. THEOCHEM 2000, 503, 17-30.
48. Pearlman, R. S.; Smith, K. M. Drugs Future 1998, 23, 885-895.
49. Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518-1520.